VirMedica, a provider of specialty pharmaceutical technology services, has acquired the assets of TransEngen. TransEngen’s core technology platform, called TIER4, automates the benefits verification process for specialty pharmaceutical products and is currently deployed by several of the world’s largest pharmaceutical companies. The $15 million dollar acquisition was financed by Petra Capital Partners and HealthQuest Capital. …...
